In Vivo Screening Data Summary

NCI In Vivo Screening Data

P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice

NSC 12861
CAS 149-45-1
SDD; Tiron; Tiferron

Chemical Data
Schedule (route) Endpoint Vehicle Dose Treated/Control (%) Observations
Q01DX009 (ip) median survival time saline 100.0 mg/kg/injection 95.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5
Q01DX009 (ip) median survival time saline 100.0 mg/kg/injection 101.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5
Q01DX009 (ip) median survival time saline 200.0 mg/kg/injection 100.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5
Q01DX009 (ip) median survival time saline 200.0 mg/kg/injection 94.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5
Q01DX009 (ip) median survival time saline 400.0 mg/kg/injection 100.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5
Q01DX009 (ip) median survival time saline 400.0 mg/kg/injection 103.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5
Q01DX009 (ip) median survival time saline 600.0 mg/kg/injection 90.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5
Q01DX009 (ip) median survival time saline 600.0 mg/kg/injection 104.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5